Detalhe da pesquisa
1.
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study.
Breast Cancer Res Treat
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38743174
2.
Primary Retroperitoneal Cystoadenocarcinoma: A Systematic Review.
Gynecol Obstet Invest
; 81(5): 385-93, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27309542
3.
Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment Strategies.
J Clin Med
; 13(7)2024 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38610638
4.
Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making.
Tumori
; : 3008916241257754, 2024 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38869029
5.
Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing.
Genes (Basel)
; 15(2)2024 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38397209
6.
RAD51 as a biomarker for homologous recombination deficiency in high-grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test.
J Pathol Clin Res
; 9(6): 442-448, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37504067
7.
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016).
J Immunother Cancer
; 11(11)2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38016718
8.
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.
Cancer Res
; 83(10): 1699-1710, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37129948
9.
The Innate Immune Microenvironment in Metastatic Breast Cancer.
J Clin Med
; 11(20)2022 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36294305
10.
Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm?
J Clin Med
; 11(23)2022 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36498813
11.
A narrative review of the principal glucocorticoids employed in cancer.
Semin Oncol
; 49(6): 429-438, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36737303
12.
HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study.
Cancers (Basel)
; 14(20)2022 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36291765
13.
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification.
Cancer Res
; 82(8): 1646-1657, 2022 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35425960
14.
Current overview and special considerations for second breast cancer in Hodgkin lymphoma survivors.
Crit Rev Oncol Hematol
; 157: 103175, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33321295
15.
Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression.
Mol Diagn Ther
; 25(4): 409-424, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33974235
16.
A review of immune checkpoint blockade in breast cancer.
Semin Oncol
; 48(3): 208-225, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34620502
17.
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers.
Front Oncol
; 11: 700853, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34552867
18.
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis.
Front Oncol
; 10: 192, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32158689
19.
Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer.
Crit Rev Oncol Hematol
; 149: 102927, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32172224
20.
Oncologist Burnout Syndrome in Eastern Europe: Results of the Multinational Survey.
JCO Oncol Pract
; 16(4): e366-e376, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32048930